Drug General Information
Drug ID
D00NPP
Former ID
DAP000715
Drug Name
Zanamivir
Synonyms
GANA; GNA; Relenza; ZMR; Zanamavir; MODIFIED SIALIC ACID; Zanamivir hydrate; GG167; GR121167X; GG-167; GR-121167X; Relenza (TN); Zanamivir (USAN/INN); (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-Guanidino-NeueAc2en; 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid; ZNV
Drug Type
Small molecular drug
Indication Influenza virus [ICD10:J11.1] Approved [536361]
Therapeutic Class
Antiviral Agents
Company
GlaxoSmithKline
Structure
Download
2D MOL

3D MOL

Formula
C12H20N4O7
Canonical SMILES
CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N
InChI
1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
InChIKey
ARAIBEBZBOPLMB-UFGQHTETSA-N
CAS Number
CAS 139110-80-8
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:50663
SuperDrug ATC ID
J05AH01
SuperDrug CAS ID
cas=139110808
Drug Resistance Mutation (DRM)
DRM DRM Info
Target and Pathway
Target(s) Neuraminidase Target Info Inhibitor [535258], [536654]
KEGG Pathway Other glycan degradation
References
Ref 536361Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20.
Ref 535258Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections. Med J Aust. 2001 Jul 16;175(2):112-6.
Ref 536654Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008 Apr;78(1):91-102. Epub 2008 Feb 4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.